<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0340">
 <label>68</label>
 <element-citation publication-type="journal" id="h0340">
  <person-group person-group-type="author">
   <name>
    <surname>Kholodenko</surname>
    <given-names>R.V.</given-names>
   </name>
   <name>
    <surname>Kalinovsky</surname>
    <given-names>D.V.</given-names>
   </name>
   <name>
    <surname>Doronin</surname>
    <given-names>I.I.</given-names>
   </name>
   <name>
    <surname>Ponomarev</surname>
    <given-names>E.D.</given-names>
   </name>
   <name>
    <surname>Kholodenko</surname>
    <given-names>I.V.</given-names>
   </name>
  </person-group>
  <article-title>Antibody fragments as potential biopharmaceuticals for cancer therapy: success and limitations</article-title>
  <source>Curr. Med. Chem.</source>
  <volume>26</volume>
  <issue>3</issue>
  <year>2019</year>
  <fpage>396</fpage>
  <lpage>426</lpage>
  <pub-id pub-id-type="pmid">28820071</pub-id>
 </element-citation>
</ref>
